Skip to main content

Table 2 Relationship between the serum FABP4 and FABP6 levels and clinicopathologic features

From: High expression of FABP4 and FABP6 in patients with colorectal cancer

Variable FABP4 P value FABP6 P value
High expression (n = 50) Low expression (n = 50) High expression (n = 50) Low expression (n = 50)
Age 56.80 ± 8.25 54.0 ± 9.36 0.144 56.16 ± 9.10 54.84 ± 8.68 0.460
Sex
 Male 24 29 0.316 28 25 0.548
 Female 26 21   22 25  
Tumor size (cm)
 ≤ 5 30 31 0.838 31 30 0.838
 > 5 20 19   19 20  
Tumor sitea
 Left colon 11 5 0.989 10 6 0.716
 Right colon 8 5   7 6  
Distant organ and lymph node metastasis
 Present 4 2 0.674 2 4 0.674
 Absent 46 48   48 46  
Histologic gradeb
 Poorly 10 12 0.887 12 10 0.748
 Moderately 35 33   34 34  
 Well 5 5   4 6  
Dukes classificationb
 A+B 23 24 0.835 26 21 0.209
 C+D 23 22   19 26  
TNM classification
 0(Tis) 4 4 0.953 5 3 0.443
 I+II 24 22   25 21  
 III+IV 22 24   20 26  
Lymphatic permeation
 Present 23 19 0.418 23 20 0.545
 Absent 27 31   27 30  
Neurological invasion
 Present 21 17 0.410 22 27 0.317
 Absent 29 33   28 23  
Vascular invasion
 Present 26 24 0.689 13 20 0.137
 Absent 24 26   37 30  
  1. aNot counting transverse colon and rectal cancer
  2. bNot counting carcinoma in situ
  3. Four carcinomas in situ in the FABP4 high and low expression group, respectively, and 5 and 3 carcinomas in situ in the FABP6 high and low expression group, respectively